Eargo 7 vs Lexie B3

The Eargo 7 is a premium-priced OTC hearing aid at $2,550, earning a B grade with a SoundScore of 3.4/5 in our lab testing. This invisible-in-ear device ranks #38 of 65 OTC hearing aids tested, placing it in the top 57% of its category. In our testing, the Eargo 7 demonstrates solid speech clarity in quiet environments, scoring 3.1/5—0.33 points above the OTC category average. Own-voice comfort also performs above average at 2.9/5, which is +0.39 points versus typical OTC devices, though only mixed in absolute terms. However, speech understanding in noisy situations is a weakness, scoring just 1.0/5, which falls 0.44 points below the category average. The most notable limitation is music streaming, which scored 0.0/5 in our lab measurements—1.92 points below the OTC average. Feedback handling is solid at 3.8/5 in absolute terms, though this is 0.74 points below the category average of 4.54/5. The Eargo 7 may appeal to users prioritizing a completely invisible design who primarily need help with speech in quieter settings. However, given its premium price point, consumers should note that several lower-priced alternatives in our database achieved higher overall sound scores. Those who frequently stream music or struggle in noisy environments may want to explore other options.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.